<b>Poster presented at EASL 2026: </b>Metabolic matters: real-world assessment of metabolic dysfunction–associated steatotic liver diseases in the United States by integrating international classification of diseases codes and non-invasive tests for improved detection

2026-09-18T09:32:17Z https://api.figshare.com/v2/oai The request includes illegal arguments, is missing required arguments, includes a repeated argument, or values for arguments have an illegal syntax.

Related documents

• Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus#854398
• AI-driven diagnostic and prognostic models for metabolic dysfunction-associated steatotic liver disease: insights from clinical, imaging, and multi-omics studies-a scoping review.#685641
• Association of metabolic dysfunction-associated steatotic liver disease trajectories with incident liver cancer: a UK Biobank cohort study.#351595
• The prognostic significance of cholesterol, high-density lipoprotein and glucose (CHG) index in evaluating all-cause mortality risk in metabolic dysfunction-associated steatotic liver disease (MASLD) individuals: evidence from two cohort studies.#221265
• Interpretable Machine Learning Models for Early Detection of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Non-Invasive Routine Clinical and Laboratory Data.#371375